We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$8.1B
AUM Growth
+$4.9B
Cap. Flow
+$4.22B
Cap. Flow %
52.11%
Top 10 Hldgs %
26.76%
Holding
6,444
New
505
Increased
3,426
Reduced
1,637
Closed
524

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$314M
2
AAPL icon
Apple
AAPL
+$247M
3
MSFT icon
Microsoft
MSFT
+$235M
4
AMZN icon
Amazon
AMZN
+$110M
5
NVDA icon
NVIDIA
NVDA
+$99M

Sector Composition

Rank Sector Weight
1 Technology 26.14%
2 Financials 11.29%
3 Healthcare 10.69%
4 Consumer Discretionary 10.28%
5 Industrials 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
POCI icon
4601
Precision Optics
POCI
$46.4M
$7.6K ﹤0.01%
1,262
+122
+11% +$737
DSS icon
4602
DSS Inc
DSS
$5.15M
$7.59K ﹤0.01%
3,164
+969
+44% +$2.94K
PRHI
4603
Presurance Holdings
PRHI
$17M
$7.59K ﹤0.01%
986
-159
-14% -$1.25K
SFE
4604
DELISTED
Safeguard Scientifics, Inc.
SFE
$7.58K ﹤0.01%
9,656
+2,071
+27% +$2.09K
PDEX icon
4605
Pro-Dex
PDEX
$213M
$7.55K ﹤0.01%
431
-261
-38% -$4.37K
FTRI icon
4606
First Trust Exchange-Traded Fund II First Trust Indxx Global Natural Resources Income ETF
FTRI
$131M
$7.54K ﹤0.01%
+579
New +$7.31K
FTK icon
4607
Flotek Industries
FTK
$1.41B
$7.54K ﹤0.01%
1,923
-644
-25% -$2.5K
CNTX icon
4608
Context Therapeutics
CNTX
$42.8M
$7.52K ﹤0.01%
6,655
-2,308
-26% -$2.48K
PWZ icon
4609
Invesco California AMT-Free Municipal Bond ETF
PWZ
$1.17B
$7.52K ﹤0.01%
301
IKT icon
4610
Inhibikase Therapeutics
IKT
$385M
$7.52K ﹤0.01%
5,919
+3,719
+169% +$3.85K
OXBR icon
4611
Oxbridge Re Holdings
OXBR
$10.5M
$7.49K ﹤0.01%
6,811
-840
-11% -$1.06K
SIDU icon
4612
Sidus Space
SIDU
$266M
$7.49K ﹤0.01%
850
+710
+507% +$5.79K
ESP icon
4613
Espey Mfg & Electronics Corp
ESP
$191M
$7.44K ﹤0.01%
398
-140
-26% -$2.38K
DLN icon
4614
WisdomTree US LargeCap Dividend Fund
DLN
$6.4B
$7.43K ﹤0.01%
112
-19,420
-99% -$1.22M
XNET
4615
Xunlei
XNET
$321M
$7.42K ﹤0.01%
+4,577
New +$7.13K
NVOS
4616
DELISTED
Novo Integrated Sciences, Inc. Common Stock
NVOS
$7.39K ﹤0.01%
+8,998
New +$18.3K
AIFA
4617
All In FutureTech Alliance Inc
AIFA
$20.3M
$7.39K ﹤0.01%
1,161
-574
-33% -$3.33K
ADN
4618
DELISTED
Advent Technologies
ADN
$7.38K ﹤0.01%
1,103
+518
+89% +$5.97K
MUI
4619
DELISTED
BlackRock Municipal Income Fund, Inc.
MUI
$7.37K ﹤0.01%
+633
New +$6.81K
LTBR icon
4620
Lightbridge
LTBR
$339M
$7.36K ﹤0.01%
2,294
-388
-14% -$1.54K
TLIS
4621
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$7.36K ﹤0.01%
988
+208
+27% +$1.35K
ALOY
4622
REalloys Inc
ALOY
$870M
$7.36K ﹤0.01%
2,610
-641
-20% -$1.75K
KINS icon
4623
Kingstone Companies
KINS
$276M
$7.34K ﹤0.01%
3,447
-3,472
-50% -$7.67K
SEEL
4624
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$7.34K ﹤0.01%
+41
New +$20.2K
JPRE icon
4625
JPMorgan Realty Income ETF
JPRE
$467M
$7.34K ﹤0.01%
163
-8,280
-98% -$339K

Similar funds

Tower Research Capital (TRC)'s Q4 2023 Portfolio in Review

As of Q4 2023, Tower Research Capital (TRC) held 6,444 positions worth $8.1B, up 153% from $3.2B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $4.22B of net new capital in Q4 2023, opening 505 new positions and adding to 3,426 existing holdings. Its largest new stake was Veralto: 28,523 shares worth $2.35M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $21.7M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2023 buy was Veralto: 28,523 shares worth $2.35M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $314M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2023 reduction was iShares MSCI EAFE ETF, cutting an estimated $21.7M.
  • Tower Research Capital (TRC) fully exited Vanguard Morningstar Total Stock Market ETF in Q4 2023, selling an estimated $6.02M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $8.1B portfolio in Q4 2023.
  • Tower Research Capital (TRC) opened 505 new positions and closed 524 in Q4 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 153% quarter-over-quarter to $8.1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.